lactic acid has been researched along with avapro in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Blanchet, M; Curnier, D; De Champlain, J; Ducharme, A; Lamoureux, MC; Racine, N; Sheppard, R; Sirois, P; Tardif, JC; White, M | 1 |
| Adams, F; Boschmann, M; Engeli, S; Franke, G; Jordan, J; Luft, FC; Sharma, AM | 1 |
| Egashira, K; Funamoto, D; Ikeda, G; Ishikita, A; Katsuki, S; Koga, J; Matoba, T; Nagaoka, K; Nakano, K; Nakano, Y; Sunagawa, K; Tokutome, M | 1 |
2 trial(s) available for lactic acid and avapro
| Article | Year |
|---|---|
Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Double-Blind Method; Drug Therapy, Combination; Enalapril; Exercise Tolerance; Female; Heart Failure; Humans; Irbesartan; Lactic Acid; Male; Middle Aged; Norepinephrine; Prospective Studies; Rest; Tetrazoles | 2005 |
Influences of AT1 receptor blockade on tissue metabolism in obese men.
Topics: Adipose Tissue; Adult; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Energy Metabolism; Ethanol; Glycerol; Humans; Irbesartan; Isoproterenol; Lactic Acid; Male; Microdialysis; Muscle, Skeletal; Obesity; Pyruvic Acid; Receptor, Angiotensin, Type 1; Tetrazoles | 2006 |
2 other study(ies) available for lactic acid and avapro
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation.
Topics: Administration, Intravenous; Animals; Biphenyl Compounds; Cardiotonic Agents; Disease Models, Animal; Drug Carriers; Irbesartan; Lactic Acid; Mice; Monocytes; Myocardial Ischemia; Myocarditis; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Reperfusion Injury; Tetrazoles; Treatment Outcome | 2016 |